Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 21, 2022 10:00 ET | Source: neurocare group AG

neurocare group AG Announces Publication Confirming the Importance of Sleep for Effectiveness of Combined rTMS and CBT for OCD

MUNICH, Nov. 21, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
September 05, 2022 03:00 ET | Source: neurocare group AG

neurocare group AG expands international footprint with cooperation in the Middle East, the Republic of Ireland and Northern Ireland

MUNICH, Sept. 05, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
August 23, 2022 16:00 ET | Source: neurocare group AG

neurocare group AG and STIMIT AG announce strategic cooperation

MUNICH, Aug. 23, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
June 23, 2022 11:00 ET | Source: neurocare group AG

neurocare group AG obtains patent grant on treatment method for neuromodulation in Japan

MUNICH, June 23, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
June 14, 2022 10:00 ET | Source: neurocare group AG

neurocare group AG continues expansion with opening of first UK clinic in London

MUNICH, June 14, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
June 08, 2022 11:00 ET | Source: neurocare group AG

neurocare group AG Announces Recent Start of a Phase III Trial Examining the Cost-Effectiveness of TMS for Patients With Exposure Therapy-Resistant OCD

MUNICH, June 08, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
May 13, 2022 11:00 ET | Source: neurocare group AG

neurocare group AG announces TGA approval of Apollo TMS System with product launch at RANZCP Congress in Sydney

MUNICH, May 13, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
May 11, 2022 03:00 ET | Source: neurocare group AG

neurocare Announces Entry Into Ketamine-Assisted Therapy Market Through Cooperation With Privatpraxis Dr. Scheib in Berlin

MUNICH, May 11, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
May 10, 2022 08:00 ET | Source: neurocare group AG

neurocare group AG announces participation at Clinical TMS Society 2022 Annual Meeting

MUNICH, May 10, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
May 06, 2022 07:31 ET | Source: neurocare group AG

neurocare group AG announces Publication in Biological Psychiatry CNNI Revealing the First Clinically Actionable EEG Biomarker in ADHD

MUNICH, May 06, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...

Next Page keyboard_arrow_right